Search Results for 'amyris'

Amyris and the Great Rate Debate

Amyris and the Great Rate Debate

March 6, 2017 |

The full-year and Q4 2016 results are in for Amyris, and there’s reason for the Hot 50 selectors, who lifted Amyris to #2 in the world this year, to cheer loudly. Revenues doubled during 2016. The production cost plunged to as low as $1.75 per liter for farnesene. There are 14 major collaborations underway which […]

Read More

Knocking on the Golden Door: The Digest’s 2017 Multi-Slide Guide to Amyris

Knocking on the Golden Door: The Digest’s 2017 Multi-Slide Guide to Amyris

March 6, 2017 |

In California, Amyris reported Q4 revenues of $32.2 million, 227% up from Q4 2015. The increase was driven by a 119% increase in product sales, primarily in the company’s personal care segment, as well as by significantly higher collaboration revenues. We reported on Amyris’ progress most recently in “The New Colossus aims to unlock its Golden Door”. Meanwhile, […]

Read More

Chevron invests in Cosan and Amyris’ Novvi producing bio-based hydrocarbon molecules

Chevron invests in Cosan and Amyris’ Novvi producing bio-based hydrocarbon molecules

December 19, 2016 |

In California, Chevron Products Co., a division of Chevron U.S.A. Inc., and Novvi LLC—a joint venture of Amyris Inc., Cosan S.A. and American Refining Group—announced that Chevron has made an equity investment into Novvi. Terms of the transaction were not disclosed. Novvi produces targeted hydrocarbon molecules from plant sugar for automotive, industrial, marine, and construction […]

Read More

Japan’s NIKKOL agrees to buy 50% of Amyris Neossance business

Japan’s NIKKOL agrees to buy 50% of Amyris Neossance business

December 13, 2016 |

In California, Amyris announced it has signed a definitive agreement to establish a cosmetic ingredients joint venture with NIKKOL GROUP (“NIKKOL”), a leading Japanese cosmetic specialty chemical provider. NIKKOL is purchasing 50% of the Amyris Neossance business for up to $20 million in total. Amyris will receive $10 million of the purchase price upfront and […]

Read More

Santamyris’ sustainable Christmas, good for investors too?

Santamyris’ sustainable Christmas, good for investors too?

December 12, 2016 |

This week, news arrived from Amyris that they have purchased the Glycotech facility in Leland, North Carolina where, since 2011, they have been on a contract basis converting their farnesene into squalane for the cosmetic markets. Total purchase price for the small manufacturer was $4.35M — a good deal for a manufacturing site with more […]

Read More

Amyris, Queensland to create Industrial Biotechnology Hub

Amyris, Queensland to create Industrial Biotechnology Hub

December 10, 2016 |

In Australia, Amyris and the Government of Queensland, Australia inked a partnership to create a southeast hub of sustainable ingredients production for the rapidly-growing personal care sector in Asia, while supporting Queensland’s local economy and sugarcane industry. The partnership aims to develop a new production plant with support from local partners. The plant will produce […]

Read More

Amyris, Kuraray extend rubber, elastomer partnership from development to joint marketing

Amyris, Kuraray extend rubber, elastomer partnership from development to joint marketing

December 4, 2016 |

In California, Amyris and Kuraray signed a multi-year extension to their collaboration agreement for the use of Amyris’s Biofene branded ß-Farnesene in liquid farnesene rubber and farnesene-based elastomer applications. This collaboration, which originally began in 2011, features increased farnesene supply to Kuraray and joint marketing of products to industry and end-customers. Kuraray’s recent technological successes […]

Read More

Arzeda produces 2 keystone molecules for Amyris-DARPA project

Arzeda produces 2 keystone molecules for Amyris-DARPA project

November 4, 2016 |

At ABLC Next in California, Arzeda reached a major technical milestone with Amyris as a part of a Defense Advanced Research Projects Agency (DARPA) Technology Investment Agreement. Arzeda’s high-throughput, automated pipeline for protein engineering and pathway discovery has been validated by the production of two keystone molecules which will now be further optimized by Amyris. […]

Read More

Revenues tripling: The Digest’s 2016 Multi-Slide Guide to Amyris

Revenues tripling: The Digest’s 2016 Multi-Slide Guide to Amyris

November 3, 2016 |

In California, Amyris reported Q3 revenues of $26.5 million, up sharply from $8.6 million for the third quarter of 2015. The increase was driven by a 61% increase in product sales, primarily in the company’s personal care segment, as well as by significantly higher collaboration revenues. Collaboration revenues contributed $19.7 million and were up from $4.4 […]

Read More

Amyris scores Biossance launch with Sephora

Amyris scores Biossance launch with Sephora

October 31, 2016 |

In California, Biossance™, the consumer beauty brand from Amyris, Inc., announced its planned launch in Sephora’s retail stores where the brand’s expansive line of high-performance skin care products will be available to consumers. The rollout to initial participating stores will begin in February 2017 and coincide with launching on Sephora online. Additional in-store and online […]

Read More